Invesco Pharmaceuticals ETF Rating → Biden Nomination CANCELED? (From The Freeport Society) (Ad) Free PJP Stock Alerts $81.14 -0.06 (-0.07%) (As of 05/16/2024 ET) Add Compare Share Share RatingsStock AnalysisChartHoldingsOwnershipRatingsStock AnalysisChartHoldingsOwnershipRatings Invesco Pharmaceuticals ETF Aggregate Rating and Price Target (2024)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.PJP Aggregate RatingModerate Buy2.72Holdings in PJP have an aggregate rating of Moderate Buy based on 226 analyst ratings issued in the past year covering 21 companies (96.3% of the portfolio).PJP Aggregate Price Target$101.4225.00% UpsideHigh Prediction$125.01Average Prediction$101.42Low Prediction$80.75Holdings in PJP have an aggregate price target of $101.42 and a range of $80.75 to $125.01 covering 21 companies (96.3% of the portfolio).PJP Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy6 Buy rating(s)Moderate Buy11 Moderate Buy rating(s)Hold4 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Invesco Pharmaceuticals ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 21 PJP Holdings Export to ExcelWeightIn ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings6.79%GERNGeron$3.904 of 5 stars2.80$6.10 56.4%5Positive News6.20%AMGNAmgen$314.72-1.4%5 of 5 stars2.52$305.65 -2.9%21Options Volume5.88%PFEPfizer$28.93+0.4%5 of 5 stars2.40$35.86 23.9%155.88%REGNRegeneron Pharmaceuticals$967.98-1.0%4 of 5 stars2.76$989.36 2.2%21Analyst ForecastInsider SellingPositive News5.79%MRKMerck & Co., Inc.$130.89-0.6%5 of 5 stars2.58$131.33 0.3%12Analyst Revision5.72%LLYEli Lilly and Company$771.12-2.0%5 of 5 stars2.84$769.53 -0.2%19Analyst ForecastShort Interest ↓5.46%JNJJohnson & Johnson$154.27+1.0%5 of 5 stars2.46$175.86 14.0%13Analyst ForecastShort Interest ↑5.23%ABBVAbbVie$164.35+0.3%4 of 5 stars2.77$174.31 6.1%13Short Interest ↑Analyst Revision5.12%ABTAbbott Laboratories$104.87+0.3%5 of 5 stars2.67$121.50 15.9%9Insider SellingShort Interest ↑Positive News4.37%UTHRUnited Therapeutics$272.22-0.2%5 of 5 stars2.90$308.78 13.4%10Analyst UpgradeInsider Selling4.32%CORTCorcept Therapeutics$27.54-1.0%5 of 5 stars3.00$40.10 45.6%4Insider SellingShort Interest ↓4.11%LGNDLigand Pharmaceuticals$85.02-0.9%5 of 5 stars3.00$116.33 36.8%3Insider Selling4.08%ANIPANI Pharmaceuticals$63.77-1.6%5 of 5 stars3.00$81.00 27.0%4Insider Selling3.75%SUPNSupernus Pharmaceuticals$29.16+1.5%4 of 5 stars3.00$41.00 40.6%1High Trading Volume3.64%BIIBBiogen$230.04-2.2%5 of 5 stars2.65$288.46 25.4%26Analyst ForecastNews Coverage3.63%PBHPrestige Consumer Healthcare$64.98-2.2%4 of 5 stars2.50$110.00 69.3%3Earnings ReportAnalyst ForecastAnalyst RevisionNews CoverageHigh Trading Volume3.60%PCRXPacira BioSciences$31.51+4.8%5 of 5 stars3.00$47.40 50.4%103.37%PRGOPerrigo$30.10-0.4%5 of 5 stars3.00$40.67 35.1%3Analyst UpgradeOptions Volume3.32%GILDGilead Sciences$67.86+1.3%5 of 5 stars2.35$83.69 23.3%173.17%JAZZJazz Pharmaceuticals$110.49+0.7%5 of 5 stars2.85$192.75 74.5%132.86%AMPHAmphastar Pharmaceuticals$42.74+0.7%5 of 5 stars2.50$66.00 54.4%4 This page (NYSEARCA:PJP) was last updated on 5/17/2024 by MarketBeat.com Staff From Our PartnersGold Set to EXPLODE!Gold Safe ExchangeHow Biden has already won 2024Porter & CompanyBiden Nomination CANCELED?The Freeport SocietyThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 Media348 million Americans lives to END as we know it?The Oxford ClubA once-in-a-century investment opportunityStansberry ResearchCharles Payne Demystifies OptionsUnstoppable ProsperityBiden FINISHED On June 13th?Paradigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Invesco Pharmaceuticals ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
